Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/26/2012WO2012143492A1 Beadlets comprising carotenoids
10/26/2012WO2012143488A1 Protein for use as a medicament
10/26/2012WO2012143427A1 Anti polyomavirus compounds
10/26/2012WO2012143416A2 Novel compounds
10/26/2012WO2012143415A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012WO2012143413A1 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
10/26/2012WO2012143405A1 Nutritional compositions having alpha-hica and alpha-ketoglutarate
10/26/2012WO2012143404A1 Nutritional compositions having alpha-hica and eicosapentaenoic acid
10/26/2012WO2012143403A1 Nutritional compositions having alpha-hica and citrulline
10/26/2012WO2012143402A1 Nutritional compositions comprising alpha-hydroxyisocaproic acid
10/26/2012WO2012143399A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
10/26/2012WO2012143377A1 Niclosamide for the treatment of cancer metastasis
10/26/2012WO2012143340A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
10/26/2012WO2012143337A1 Novel modulators of cortical dopaminergic- and nmda-receptor-mediated glutamatergic neurotransmission
10/26/2012WO2012143329A1 Triazolopyridines
10/26/2012WO2012143324A1 Cartilage product
10/26/2012WO2012143320A1 (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
10/26/2012WO2012143308A1 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
10/26/2012WO2012143293A1 Method for purification of micafungin
10/26/2012WO2012143248A1 Substituted pyrimidinyl-pyrroles active as kinase inhibitors
10/26/2012WO2012143144A1 Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors
10/26/2012WO2012143143A1 Heterocyclic compounds as kinase inhibitors
10/26/2012WO2012143141A2 Antiviral compositions directed against the influenza virus nucleoprotein
10/26/2012WO2012143117A1 2-oxo-1-imidazolidinyl imidazothiadiazole derivatives
10/26/2012WO2012143116A1 4-oxo-1-imidazolidinyl imidazothiadiazole derivatives
10/26/2012WO2012143041A1 Composition, method for its manufacture and use thereof
10/26/2012WO2012143012A1 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
10/26/2012WO2012143011A1 Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice
10/26/2012WO2012143008A1 Reduction of the level of free phosphorus compounds in the digestive juice
10/26/2012WO2012142960A1 Erythromycin ethylsuccinate crystalline hydrate, preparation and uses thereof
10/26/2012WO2012142958A1 Tigecycline crystalline hydrate and preparation method therefor and use thereof
10/26/2012WO2012142926A1 Camptothecin compound containing stable 7-membered lactone ring, preparation method and use
10/26/2012WO2012142724A1 New low side effect pharmaceutical composition containing antituberculosis drugs
10/26/2012WO2012142698A1 Alkylurea derivatives active against cancer cells
10/26/2012WO2012142678A1 Weight loss composition
10/26/2012WO2012142671A1 Aromatic amides and uses thereof
10/26/2012WO2012142669A1 A method for the treatment of a solid tumour
10/26/2012WO2012142666A1 Method of modulating amine oxidase activity and agents useful for same
10/26/2012WO2012118857A3 Immunologically modified carbon nanotubes for cancer treatment
10/26/2012WO2012118309A3 Pyrazole derivatives, preparation method thereof, and composition for preventing and treating osteoporosis containing same
10/26/2012WO2012118308A9 Composition for preventing and treating cardiovascular diseases, containing pyrazole derivative
10/26/2012WO2012118277A3 Composition for promoting hematogenesis, containing quercetin 3-o-β-(2''-galloyl)rhamnoside as active ingredient
10/26/2012WO2012117076A3 Baclofen and acamprosate based therapy of neurogical disorders
10/26/2012WO2012116935A3 Gene cluster for biosynthesis of cycloclavine
10/26/2012WO2012116010A3 Antibiotic tolerance inhibitors
10/26/2012WO2012111996A3 Transdermal delivery system containing galantamine or salts thereof
10/26/2012WO2012111961A3 Orally administrated sustained-release tablet containing tianeptine or pharmaceutically acceptable salt thereof
10/26/2012WO2012109473A8 Detection of endotoxins
10/26/2012WO2012108794A3 1,2,4-triazol-3-ylthioglycolic acid derivatives for use in therapy
10/26/2012WO2012108738A3 Sildenafil-free base-containing film preparation and method for producing same
10/26/2012WO2012108631A3 Pharmaceutical compositions comprising revaprazan-containing nanoparticles and processes for the preparation thereof
10/26/2012WO2012105767A3 Antiarrhythmic agent preparations having a ph-independent dissolution profile
10/26/2012WO2012104550A3 INHIBITORS OF THE INTERACTION OF THE SIGMA-1 RECEPTOR WITH hERG FOR USE IN THE TREATMENT OF CANCER
10/26/2012WO2012099980A3 Equine nutritional supplement
10/26/2012WO2012099557A3 Fatty acid inhibitors
10/26/2012WO2012097177A3 Substituted benzoazepines as toll-like receptor modulators
10/26/2012WO2012094598A3 Pharmaceutical compositions of iron for oral administration
10/26/2012WO2012094283A3 Bepotastine compositions
10/26/2012WO2012092594A3 Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables
10/26/2012WO2012092160A3 Neutral human milk oligosaccharides to promote growth of beneficial bacteria
10/26/2012WO2012088306A3 Two-piece injectable drug delivery device with heat-cured seal
10/26/2012WO2012088268A3 Modulators for sirt6 and assays for screening same
10/26/2012WO2012088038A3 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
10/26/2012WO2012082942A3 Neuropeptide analogs, compositions, and methods for treating pain
10/26/2012WO2012082903A3 Treatment of cognitive impairment in a subject with a neurological autoimmune disease
10/26/2012WO2012082718A3 3-methanesulfonylpropionitrile for treating inflammation and pain
10/26/2012WO2012080727A4 Casein kinase 1delta (ck1delta) inhibitors
10/26/2012WO2012075242A3 Controlled chemical release of hydrogen sulfide
10/26/2012WO2012056387A3 A dermaceutical gel made using sodium fusidate and a process to make it
10/26/2012WO2012027462A9 Compositions and methods for treating neoplasia
10/26/2012WO2012018948A3 Combination therapy for the treatment of prostate carcinoma
10/26/2012WO2011146876A3 Oral transmucosal administration of sufentanil
10/26/2012WO2011127200A8 Methods of treatment using 3-bromopyruvate and other selective inhibitors of atp production
10/26/2012WO2011119663A8 Chemical compounds
10/26/2012WO2011113606A8 Anti-infective compounds
10/26/2012WO2011113005A8 Compositions and methods for combinations of oligoamines with 2-difluoromethylornithine (dfmo)
10/26/2012WO2011085990A8 Anti - infective pyrido (1,2 -a) pyrimidines
10/26/2012CA2861440A1 Method for combined conditioning and chemoselection in a single cycle
10/26/2012CA2855469A1 Compositions and methods for nutritional supplementation
10/26/2012CA2839773A1 Recombinant virus products and methods for inhibition of expression of myotilin
10/26/2012CA2833961A1 Fatty acid amide hydrolase inhibitors for treating pain
10/26/2012CA2833766A1 Modulation of hepatitis b virus (hbv) expression
10/26/2012CA2833698A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
10/26/2012CA2833657A1 Triazolopyridines
10/26/2012CA2833648A1 1,4-disubstituted 1,2,3-triazoles, methods for preparing same, and diagnostic and therapeutic uses thereof
10/26/2012CA2833633A1 Composition and method for enhancing an immune response
10/26/2012CA2833574A1 Chewing gum comprising chitosan for use in reduction of the level of free phosphorus compounds in the digestive juice
10/26/2012CA2833547A1 Methods and compositions suitable for preventing and treating hyperleptinemia
10/26/2012CA2833545A1 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/26/2012CA2833534A1 Molecular subtyping, prognosis and treatment of prostate cancer
10/26/2012CA2833474A1 Method for producing patch, and patch
10/26/2012CA2833413A1 A method for the treatment of a solid tumour
10/26/2012CA2833377A1 Benzothiazole compounds and their pharmaceutical use
10/26/2012CA2833339A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
10/26/2012CA2833320A1 Dibenzothiazepine derivatives and their use in the treatment of cns disorders
10/26/2012CA2833288A1 Substituted 4-aryl-n-phenyl-1,3,5-triazin-2-amines
10/26/2012CA2833223A1 New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1)
10/26/2012CA2833009A1 Insulin-like growth factor-1 receptor inhibitors
10/26/2012CA2833006A1 Taste-masked formulations of raltegravir
10/26/2012CA2832992A1 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
1 ... 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 ... 7860